Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A van Hout

Showing results (41-50 of 126) with videos related to

Pageof 13
Sort By:
Journal of Health Economics|January 6, 2000
Estimating parametric relationships between health description and health valuation with an application to the EuroQol EQ-5DJ J Busschbach, J McDonnell, M L Essink-Bot, et al.
Journal of Managed Care & Specialty Pharmacy|May 24, 2017
The Importance of Economic Perspective and Quantitative Approaches in Oncology Value Frameworks of Drug Selection and Shared Decision MakingA Reginald Waldeck, Marc F Botteman, Richard E White, et al.
Health Economics|September 1, 1994
Costs, effects and C/E-ratios alongside a clinical trialB A van Hout, M J Al, G S Gordon, et al.
Health Economics|July 31, 1998
Sample size calculation in economic evaluationsM J Al, B A van Hout, B C Michel, et al.
Public Health Nutrition|May 3, 2013
Effects of salt labelling and repeated in-home consumption on long-term liking of reduced-salt soupsAstrid A Willems, Danielle H A van Hout, Nicolien Zijlstra, et al.
Progress in Cardiovascular Diseases|November 11, 1999
Economic evaluation in the field of cardiology: theory and practiceB A van Hout, E S Goes, E W Grijseels, et al.
Critical Care (London, England)|August 18, 2004
Prevalence and incidence of severe sepsis in Dutch intensive care unitsAukje van Gestel, Jan Bakker, Christiaan P W M Veraart, et al.
Journal of Health Services Research & Policy|September 4, 1996
Simulation models in the planning of health care facilities: an application in the case of neonatal extracorporeal membrane oxygenationB C Michel, R J van Staveren, W B Geven, et al.
Applied Health Economics and Health Policy|June 29, 2010
Costs and consequences of clopidogrel versus aspirin for secondary prevention of ischaemic events in (high-risk) atherosclerotic patients in Sweden: a lifetime model based on the CAPRIE trial and high-risk CAPRIE subpopulationsJ Floris S Logman, Bart M S Heeg, Johan Herlitz, et al.
Pharmacoeconomics|September 7, 2007
Long-term clopidogrel therapy in patients receiving percutaneous coronary interventionBart M S Heeg, Ron J G Peters, Marc Botteman, et al.
Pageof 13

Showing results (41-50 of 126) with videos related to

Sort By:
Pageof 13
Journal of Health Economics|January 6, 2000
Estimating parametric relationships between health description and health valuation with an application to the EuroQol EQ-5DJ J Busschbach, J McDonnell, M L Essink-Bot, et al.
Journal of Managed Care & Specialty Pharmacy|May 24, 2017
The Importance of Economic Perspective and Quantitative Approaches in Oncology Value Frameworks of Drug Selection and Shared Decision MakingA Reginald Waldeck, Marc F Botteman, Richard E White, et al.
Health Economics|September 1, 1994
Costs, effects and C/E-ratios alongside a clinical trialB A van Hout, M J Al, G S Gordon, et al.
Health Economics|July 31, 1998
Sample size calculation in economic evaluationsM J Al, B A van Hout, B C Michel, et al.
Public Health Nutrition|May 3, 2013
Effects of salt labelling and repeated in-home consumption on long-term liking of reduced-salt soupsAstrid A Willems, Danielle H A van Hout, Nicolien Zijlstra, et al.
Progress in Cardiovascular Diseases|November 11, 1999
Economic evaluation in the field of cardiology: theory and practiceB A van Hout, E S Goes, E W Grijseels, et al.
Critical Care (London, England)|August 18, 2004
Prevalence and incidence of severe sepsis in Dutch intensive care unitsAukje van Gestel, Jan Bakker, Christiaan P W M Veraart, et al.
Journal of Health Services Research & Policy|September 4, 1996
Simulation models in the planning of health care facilities: an application in the case of neonatal extracorporeal membrane oxygenationB C Michel, R J van Staveren, W B Geven, et al.
Applied Health Economics and Health Policy|June 29, 2010
Costs and consequences of clopidogrel versus aspirin for secondary prevention of ischaemic events in (high-risk) atherosclerotic patients in Sweden: a lifetime model based on the CAPRIE trial and high-risk CAPRIE subpopulationsJ Floris S Logman, Bart M S Heeg, Johan Herlitz, et al.
Pharmacoeconomics|September 7, 2007
Long-term clopidogrel therapy in patients receiving percutaneous coronary interventionBart M S Heeg, Ron J G Peters, Marc Botteman, et al.
Pageof 13